首页|高血压合并糖尿病治疗中硝苯地平控释片的作用研究

高血压合并糖尿病治疗中硝苯地平控释片的作用研究

扫码查看
目的 研究硝苯地平控释片在治疗高血压合并糖尿病中的具体意义.方法 本研究选择 60 例患者(均属于高血压合并糖尿病)进行分组(随机方法)为对照组(30 例治疗方法为降糖和加氯沙坦钾治疗)以及实验组(30 例治疗方法为在对照组治疗基础上增加硝苯地平控释片治疗).比较两组治疗前后相关指标[收缩压、舒张压、心率以及血肌酐(SCr)、尿素氮(BUN)],治疗效果,不良反应发生率.结果 治疗前,两组的收缩压、舒张压、心率以及SCr、BUN无差异性(P>0.05);治疗后,实验组的收缩压(125.42±0.45)mm Hg(1 mm Hg=0.133 kPa)、舒张压(80.45±3.13)mm Hg、心率(74.02±0.34)次/min以及SCr(87.51±0.12)μmol/L、BUN(5.56±0.03)mmol/L均低于对照组的(140.45±3.46)mm Hg、(86.78±3.46)mm Hg、(76.78±0.54)次/min、(90.42±0.21)μmol/L、(5.90±0.32)mmol/L,统计学差异性十分显著(P<0.05).实验组的治疗总有效率为 96.67%,对照组的治疗总有效率为 73.33%,实验组的治疗总有效率高于对照组,组间对比统计学意义存在(P<0.05).实验组和对照组不良反应发生率分别为6.67%、36.67%,组间对比统计学意义存在(P<0.05).结论 高血压合并糖尿病治疗中应用硝苯地平控释片的作用明显,能够使患者治疗效果提升,降低不良反应发生率,且患者的收缩压和舒张压都能得到控制,临床总体应用价值高.
Effect of nifedipine controlled-release tablets in the treatment of hypertension complicated with diabetes
Objective To study the specific significance of nifedipine controlled release tablets in the treatment of hypertension combined with diabetes disease.Methods The diseases of the patients in this study were hypertension and diabetes,and 60 patients were compared by group(random method),the control group(30 patients,were hypoglycemic and losartan treatment)and the experimental group(30 patients,nifedipine controlled-release treatment was added on the treatment of the control group).Compared the relevant indicators before and after treatment[systolic blood pressure,diastolic blood pressure,heart rate,blood creatinine(SCr),blood urea nitrogen(BUN)],the treatment effect and the incidence of adverse reactions.Results Before the treatment,There was no difference in systolic,diastolic blood pressure,heart rate,SCr and BUN between the two groups(P>0.05);post-treatment,The systolic blood pressure(125.42±0.45)mm Hg(1 mm Hg=0.133 kPa),diastolic blood pressure(80.45±3.13)mm Hg,heart rate(74.02±0.34)times/min,and SCr(87.51±0.12)μmol/L,BUN(5.56±0.03)mmol/L were all lower than the control group(140.45±3.46)mm Hg,(86.78±3.46)mm Hg,(76.78±0.54)times/min,(90.42±0.21)μmol/L,(5.90±0.32)mmol/L,The statistical difference was very significant(P<0.05).The total response rate of the experimental group was 96.67%,and the total response rate of the control group was 73.33%.The total response rate of the experimental group was higher than that of the control group,and the significance was determined by the comparison results between the groups(P<0.05).In the inter-group analysis of the incidence of adverse reactions,the values of the experimental group and the control group were 6.67%and 36.67%,respectively,and the proportional significance of the incidence of adverse reactions existed(P<0.05).Conclusion The effect of nifedipine controlled release tablet in the treatment of hypertension combined with diabetes is obvious,which can improve the treatment effect of patients,reduce the incidence of adverse reactions,and the systolic and diastolic blood pressure of patients can be controlled,and the overall clinical application value is high.

HypertensionDiabetesNifedipine controlled-release tablets

罗敏

展开 >

353000 南平市第一医院

高血压 糖尿病 硝苯地平控释片

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(10)